May 02, 2022 / 01:30PM GMT
Vincent Nadeau - Bloom Burton & Co. - Analyst
Welcome to the 2022 Bloom Burton Healthcare Investment Conference this morning. You are in Hall C and D, which is a large hall. This morning, we have a series of sessions, series of presentations with biotech companies. We will have also a fireside chat midway through with BELLUS Health. But to start, we have Carl Hansen here, Chairman, CEO and President of AbCellera Biologics. Carl, take it away.
Carl Hansen - AbCellera Biologics Inc. - Chairman, CEO & President
All right, thank you so much. Can everyone hear me? Great. So first, let me say what a pleasure it is to finally be back in three dimensions after three years. We had a terrific dinner last night and conversation, got to meet many of the people that I've only met through Zoom, and also to reconnect with some old friends. I really think that Canada has a remarkable community in terms of the support and people cheering for each other across the country. And it's really heartwarming to be back, back in that event, and so I wanted to thank the team of
Abcellera Biologics Inc at Bloom Burton & Co. Healthcare Investor Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot